Analyst Ratings for Prime Medicine (PRME)
PRME Rating Summary
PRME Price Target Summary
- Highest: $26.00 (JPMorgan)
- Lowest: $9.00 (Stifel)
- Average: $17.22
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$17.22 (+258.8%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/22/2024 | Chardan Capital Markets | Geulah Livshits | New Coverage | Buy (N/A) |
17.00 (N/A) |
4.51 (4.80) |
6.43% | Details |
| 4/8/2024 | TD Cowen | Joseph Thome | New Coverage | Buy (N/A) |
N/A (N/A) |
5.75 (4.80) |
-16.52% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
